Temple University Hospital
Philadelphia, Pennsylvania, 191440, United States
NCT Number: NCT00779701
Glycemic control can be safely achieved in surgical and medical intensive care unit settings and has been shown to improve short and long-term clinical outcomes. As such, insulin infusion protocols are routinely used in the ICU setting. The investigators plan to establish the use of strict glycemic control in a heterogenous group of acutely ill patients in the ED setting. The investigators propose to study the aspects of implementing a strict glycemic control protocol in the ED.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Philadelphia, Pennsylvania, 191440, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
APACHE II score ≥9 (See Appendix 1) OR >2 SIRS criteria with lactate ≥ 4 or BP < 90mmHg despite one liter of fluid OR Evidence of Organ Dysfunction (see Appendix 1)
Exclusion criteria
Insulin infusion titrated to patients blood glucose to maintain blood glucose between 80-110mg/dL
Time frame: Study duration 6 hours. Blood glucose checked at 30 minutes then every 15 minutes until within target blood glucose range then every hour.
Temple University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686939
Glucose Metabolism Disorders, Glycemic Control
Taizhou, Zhejiang, China
View Trial DetailsNCT05557227
Glucose Metabolism Disorders, Hyperglycemia
Aarhus, Region Midt, Denmark
View Trial DetailsNCT07669389
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chiang Rai, Changwat Chiang Rai, Thailand
View Trial DetailsNCT04001049
Brain Diseases, Brain Ischemia
Madrid, Spain
View Trial Details